Trial Profile
Systolic and Pulse Pressure Hemodynamic Improvement By Restoring Elasticity: the SILVER study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Oct 2005
Price :
$35
*
At a glance
- Drugs Alagebrium chloride (Primary)
- Indications Isolated systolic hypertension
- Focus Therapeutic Use
- Acronyms SILVER
- 15 Oct 2005 New trial record.